» Articles » PMID: 37511521

Esaxerenone Inhibits Renal Angiogenesis and Endothelial-Mesenchymal Transition Via the VEGFA and TGF-β1 Pathways in Aldosterone-Infused Mice

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Jul 29
PMID 37511521
Authors
Affiliations
Soon will be listed here.
Abstract

Renal fibrosis is an inevitable process in the progression of chronic kidney disease (CKD). Angiogenesis plays an important role in this process. Vascular endothelial cells are involved in renal fibrosis by phenotypic transformation and secretion of extracellular matrix. Aldosterone stimulates mineralocorticoid receptor (MR) activation and induces inflammation, which is important for angiogenesis. Clinically, MR blockers (MRBs) have a protective effect on damaged kidneys, which may be associated with inhibition of angiogenesis. In this study, we used aldosterone-infused mice and found that aldosterone induced angiogenesis and that endothelial-mesenchymal transition (EndMT) in neovascular endothelial cells was involved in renal fibrosis. Notably, aldosterone induced inflammation and stimulated macrophages to secrete vascular endothelial growth factor (VEGF) A to regulate angiogenesis by activating MR, whereas EndMT occurred in response to transforming growth factor-β1 (TGF-β1) induction and participated in renal fibrosis. These effects were antagonized by the MRB esaxerenone. These findings suggest that reducing angiogenesis may be an effective strategy for treating renal fibrosis.

Citing Articles

Mineralocorticoid receptor antagonism for non-diabetic kidney disease.

Jaisser F, Barrera-Chimal J Nephrol Dial Transplant. 2025; 40(Supplement_1):i29-i36.

PMID: 39907538 PMC: 11795674. DOI: 10.1093/ndt/gfae241.


Cyanoacrylate Adhesives for Cutaneous Wound Closure.

Viana I, Di Filippo P, Gobbi F, Ribeiro R, Carra G, Ribeiro L Animals (Basel). 2024; 14(18).

PMID: 39335267 PMC: 11428703. DOI: 10.3390/ani14182678.


Esaxerenone Attenuates Aldosterone-Induced Mitochondrial Damage-Mediated Pyroptosis in Mouse Aorta and Rat Vascular Smooth Muscle Cells.

Xian Y, Wang X, Chang Y, Qiang P, Han Y, Hao J Life (Basel). 2024; 14(8).

PMID: 39202709 PMC: 11355590. DOI: 10.3390/life14080967.


Esaxerenone Protects against Diabetic Cardiomyopathy via Inhibition of the Chemokine and PI3K-Akt Signaling Pathway.

Li Z, Zhang H, Zheng W, Yan Z, Yang J, Li S Biomedicines. 2023; 11(12).

PMID: 38137541 PMC: 10741975. DOI: 10.3390/biomedicines11123319.

References
1.
Ferreira N, Tostes R, Paradis P, Schiffrin E . Aldosterone, Inflammation, Immune System, and Hypertension. Am J Hypertens. 2020; 34(1):15-27. PMC: 7891246. DOI: 10.1093/ajh/hpaa137. View

2.
Fahey E, Doyle S . IL-1 Family Cytokine Regulation of Vascular Permeability and Angiogenesis. Front Immunol. 2019; 10:1426. PMC: 6603210. DOI: 10.3389/fimmu.2019.01426. View

3.
Carmeliet P . Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000; 6(4):389-95. DOI: 10.1038/74651. View

4.
Basile D, Friedrich J, Spahic J, Knipe N, Mang H, Leonard E . Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury. Am J Physiol Renal Physiol. 2010; 300(3):F721-33. PMC: 3064142. DOI: 10.1152/ajprenal.00546.2010. View

5.
Gao X, Yamazaki Y, Tezuka Y, Omata K, Ono Y, Morimoto R . Pathology of Aldosterone Biosynthesis and its Action. Tohoku J Exp Med. 2021; 254(1):1-15. DOI: 10.1620/tjem.254.1. View